| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Analysis of genotypic and phenotypic clinical cut-off levels for ritonavir-boosted saquinavir
|
Hill, A
|
|
2006
|
7 |
2 |
p. 67-74
|
article
|
| 2 |
A prospective, 96-week study of the impact of Trizivir®, Combivir®/nelfinavir, and lamivudine/stavudine/nelfinavir on lipids, metabolic parameters and efficacy in antiretroviral-naive patients: effect of sex and ethnicity
|
Kumar, PN
|
|
2006
|
7 |
2 |
p. 85-98
|
article
|
| 3 |
Characterization of nelfinavir binding to plasma proteins and the lack of drug displacement interactions
|
Motoya, T
|
|
2006
|
7 |
2 |
p. 122-128
|
article
|
| 4 |
Depression and neurocognitive performance in individuals with HIV/AIDS: 2-year follow-up
|
Gibbie, T
|
|
2006
|
7 |
2 |
p. 112-121
|
article
|
| 5 |
HIV-related neutropaenia exacerbated by efavirenz
|
Healy, BJ
|
|
2006
|
7 |
2 |
p. 129-131
|
article
|
| 6 |
Immunological and virological responses to highly active antiretroviral therapy in a non-clinical trial setting in a developing Caribbean country
|
Kilaru, KR
|
|
2006
|
7 |
2 |
p. 99-104
|
article
|
| 7 |
Minor changes in calculated creatinine clearance and anion-gap are associated with tenofovir disoproxil fumarate-containing highly active antiretroviral therapy
|
Winston, A
|
|
2006
|
7 |
2 |
p. 105-111
|
article
|
| 8 |
nef gene sequence variation among HIV-1-infected African children *
|
Chakraborty, R
|
|
2006
|
7 |
2 |
p. 75-84
|
article
|
Journal description